Diet based on oil of seeds of Brassica napus. Implications for the prevention and treatment of prostate diseases

• Autorzy: Kujawski R. , Baraniak J. , Kania M. , Bartkowiak-Wieczorek J. , Bogacz A. , Ozarowski M. , Cichocki M. , Spoz E. , Mikolajczak P.L.

Warianty tytułu

PL

Dieta na bazie oleju z nasion brassica napus. implikacje w prewencji i terapii schorzeń prostaty

• Języki publikacji: EN

Abstrakty

EN

In last centuries, human diet has been modified due to changes in the technological, economic, and cultural mode of the social life. The rapid development of the technology and advances in food production and processing of plants resulted in changes in the structure of consumption. The consequence is an growing interest among researchers, but also among consumers in searching for new alternatives to classical pharmacology, preventive solutions, and therapeutic strategies of age related, chronic diseases and cancer. In this paper, the authors have attempted to assess the benefits of usage in diet cold-pressed oils extracted from the seeds of Brassica napus (oilseed rape) with particular emphasis on the evidence of possible use of B. napus oil, and other bio-active substances contained therein, in the prevention and symptomatic treatment of prostate diseases, including benign prostatic hyperplasia (BPH). The authors postulate that the information presented in this paper may be important and helpful in the development of new, effective and safe forms of prevention and treatment of progressive age-related disorders (phytotherapeutics) and nutritional strategies (dietary supplements) based on seeds oil of Brassicace family representatives, especially Brassica napus (pollen).

PL

W ostatnich stuleciach ludzka dieta została istotnie zmodyfikowana w wyniku zmian trybu technologicznych, ekonomicznych i kulturalnych. Szybki rozwój technologii i postęp w produkcji i przetwórstwie żywności z roślin spowodował zmiany w strukturze konsumpcji. Konsekwencją tych zdarzeń jest wzrost zainteresowania naukowców oraz konsumentów poszukiwaniem nowych, alternatywnych strategii żywieniowych, a także profilaktyką schorzeń towarzyszących okresowi starzenia się, jak również chorób przewlekłych i nowotworowych. W niniejszej pracy autorzy podjęli próbę przybliżenia korzyści wynikających ze stosowania diety zawierającej tłoczony na zimno olej uzyskiwany z nasion Brassica napus (rzepak), ze szczególnym uwzględnieniem dowodów świadczących o możliwości wykorzystania oleju z B. napus, substancji bioaktywnych w nim zawartych w prewencji i leczeniu objawowym schorzeń prostaty, w tym BPH. Autorzy sugerują, że informacje zawarte w niniejszej pracy mogą być istotne i pomocne w opracowaniu nowych, skutecznych i bezpiecznych form prewencji i leczenia objawowego schorzeń postępujących wraz z wiekiem (fitoterapeutyki) oraz strategii żywieniowych (suplementy diety) opartych na bazie oleju z nasion wybranych przedstawicieli rodziny Brassicaceae, w tym Brassica napus.

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2014
• Tom: 60
• Numer: 3
• Opis fizyczny: p.77-88,ref.

Twórcy

autor

Kujawski R.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland

autor

Baraniak J.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland

autor

Kania M.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland

autor

Bartkowiak-Wieczorek J.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland
• Laboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Sw. Marii Magdaleny 14 61-861 Poznan, Poland

autor

Bogacz A.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland
• Laboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Sw. Marii Magdaleny 14 61-861 Poznan, Poland

autor

Ozarowski M.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland
• Chair and Department of Pharmaceutical Botany and Plant Biotechnology, Poznan University of Medical Sciences, Sw. Marii Magdaleny 14, 61-861 Poznan, Poland

autor

Cichocki M.

• Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Swiecickiego 4, 60-781 Poznan, Poland

autor

Spoz E.

• Department of General Pharmacology and Pharmacoeconomy, Pomeranian Medical University, Zolnierska 48, 70-204 Szczecin, Poland

autor

Mikolajczak P.L.

• Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Libelta 27, 61-707 Poznan, Poland
• Chair and Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland

Bibliografia

• 1. Ezzati M., Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science 2012; 337(6101):1482-1487.
• 2. Carrera-Bastos P, Fontes-Villalba M, O’Keefe JH, Lindeberg S, Loren Cordain L. The western diet and lifestyle and diseases of civilization. Res Rep Clin Cardiol 2011; 2:15-35.
• 3. Wang B, Zhang X. Inhibitory effects of Broccolini leaf flavonoids on human cancer cells. Scanning 2012; 34(1):1-5.
• 4. Cichosz G., Czeczot H. Spuriously unhealthy animal fats. Pol Merk Lek 2011; 185:318-322.
• 5. Palomäki A, Pohjantähti-Maaroos H, Wallenius M, Kankkunen P, Aro H, Husgafvel S, Pihlava JM, Oksanen K. Effects of dietary cold-pressed turnip rapeseed oil and butter on serum lipids, oxidized LDL and arterial elasticity in men with metabolic syndrome. Lipids Health Dis 2010; 9:137.
• 6. Obiedzińska A., Waszkiewicz-Robak B. Cold presses oils as functional food. Żywność. Nauka. Technologia. Jakość 2012; 1(80):27-44.
• 7. Gunstone FD. Vegetable oils in food technology. Composition, properties and uses. Blackwell Publishing Ltd., 2002: 38-52.
• 8. Karłowicz-Bodalska K., Bodalski T. The biological properties of unsaturated fatty acids and their role in therapy. Postępy Fitoterapii 2007; 1:46-56.
• 9. Mori TA. Omega-3 fatty acids and blood pressure. Cell Mol Biol 2010; 56(1):83-92.
• 10. Zhang W, Hu X, Yang W, Gao Y, Chen J. Omega-3 polyunsaturated fatty acid supplementation confirms long-term neuroprotection against neonatal hypoxic -ischemic brain injury through anti-inflammatory actions. Stroke 2010; 41:2341-47.
• 11. Azrad M, Denmark-Wahnefried W. Dietary omega-6 and omega-3 fatty acids and prostate cancer - letter. Cancer Prev Res (Phila) 2012; 5(5):798-99.
• 12. Lieberman R. Chemoprevention of prostate cancer: current status and future directions. Cancer Metastasis Rev 2002; 21(3-4):297-309.
• 13. Gravas S, Oelke M. Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH. World J Urol 2010; 28(1):9-15.
• 14. Parsons JK, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, Kristal AR. Finasteride Reduces the Risk of Incident Clinical Benign Prostatic Hyperplasia. Eur Urol 2012; 61(6):1263-1270.
• 15. Hamilton RJ., Andriole GL., Freedland SJ. 5α-reductase inhibitors: preventing the treatable. Eur Urol 2012; 62(2):242-4.
• 16. Lepor H. Medical treatment of benign prostatic hyperplasia. Rev Urol 2011; 13(1):20-33.
• 17. Mirone V, Sessa A, Giuliano F, Berges R, Kirby M, Moncada I. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events. Int J Clin Pract 2011; 65(9):1005-13.
• 18. Schmitz-Dräger BJ, Bismarck E, Schöffski O, Fischer C. Chemoprevention of prostate cancer - a plea. Aktuelle Urol 2012; 43(3):157-61.
• 19. Thomson JO, Dzubak P, Hajduch M. Prostate cancer and the food supplement, PC-SPES. Minireview. Neoplasma 2002; 49(2):69-74.
• 20. Bormann HL, Melizg MF. Inhibition of metallopeptidases by flavonoids and related compounds. Pharmazie 2000; 55:129-32.
• 21. Kiss A, Kowalski J, Melzig MF. Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B. Phytomedicine 2006; 13(4):284-289.
• 22. Vitalone A, McColl J, Thome D, Costa LG, Tita B. Characterization of the effect of Epilobium extracts on human cell proliferation. Pharmacology 2003; 69(2):79-87.
• 23. Azimi H, Khakshur AA, Aghdasi I, Fallah-Tafti M, Abdollahi M. A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents. Inflamm Allergy Drug Targets. 2012; 11(3):207-221.
• 24. Kujawski R, Mrozikiewicz PM, Bogacz A, Cichocka J, Mikołajczak PŁ, Czerny B, Bobkiewicz-Kozłowska T, Grześkowiak E. Influence of standardized extract of Epilobium angustifolium on estrogen receptor alpha and beta expression in in vivo model. Ginekol Pol 2010; 81(8):600-605.
• 25. Kumar N, Rungseevijitprapa W, Narkkhong NA, Suttajit M, Chaiyasut C. 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment. J Ethnopharmacol 2012; 139(3):765-771.
• 26. Kujawski R, Bartkowiak-Wieczorek J, Ożarowski M, Bogacz A, Cichocka J, Karasiewicz M, Czerny B, Mrozikiewicz PM. Current knowledge on phytochemical profile of Epilobium sp. raw materials and extracts. Potential benefits in nutrition and phytotherapy of age-related diseases. Herba Pol 2011; 57(4):25-34.
• 27. Kujawski R, Bartkowiak-Wieczorek J. Selected biological properties of herbal raw materials of the genus Epilobium in terms of the issues of prevention of prostate disease during andropause. Post Farm 2012; 1-2:16-21.
• 28. PDR [Physicians Desk Reference] for Herbal Medicines, 4th Edition, 2007:903-904.
• 29. Seo EK, Kim KH, Kim MK, Cho MH, Choi E, Kim K, Mar W. Inhibitors of 5alpha - reductase type I in LNCaP cells from the roots of Angelica koreana. Planta Med 2002; 68(2):162-163.
• 30. Park WS, Son ED, Nam GW, Kim SH, Noh MS, Lee BG, Jang IS, Kim SE, Lee JJ, Lee CH. Torilin from Torilis japonica, as a new inhibitor of testosterone 5 alpha-reductase. Planta Med 2003; 69(5):459-461.
• 31. Macdonald R, Tacklind JW, Rutks I, Wilt TJ. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review. BJU Int 2012; 109(12):1756-1761.
• 32. Liang T, Liao S. Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem J 1992; 285(2):557-562.
• 33. Abe M, Ito Y, Oyunzul L, Oki-Fujino T, Yamada S. Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract. Biol Pharm Bull 2009; 32(4):646-50.
• 34. Ducrey B, Marston A, Göhring S, Hartmann RW, Hostettmann K. Inhibition of 5 alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species. Planta Med 1997; 63(2):111-114.
• 35. van Poppel G, Verhoeven DT, Verhagen H, Goldbohm RA. Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 1999; 472:159-168.
• 36. Raynaud JP, Cousse H, Martin PM. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. J Steroid Biochem Mol 2002; 82(2-3):233-239.
• 37. Hall JC, Sytsma KJ, Iltis HH. Phylogeny of Capparaceae and Brassicaceae based on chloroplast sequence data. Am J Botan. 2002; 89(11):1826-1842.
• 38. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB. Cruciferous vegetables, genetic polymorphisms in glutathione s-transferases m1 and t1, and prostate cancer risk. Nutr Cancer 2004; 50:206-213.
• 39. Smiechowska A, Bartoszek A, Namieśnik J. Cancer chemopreventive agents: glucosinolates and their decomposition products in white cabbage (Brassica oleracea var. Capitata). Postepy Hig Med Dosw 2008; 2(62):125-140.
• 40. Vasanthi HR., Mukherjee S., Das DK. Potential health benefits of broccoli- a chemico-biological overview. Mini Rev Med Chem 2009; 9(6):749-759.
• 41. Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, van den Brandt PA. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 1996; 5(9):733-748.
• 42. Cartea ME, Francisco M, Soengas P, Velasco P. Phenolic compounds in Brassica vegetables. Molecules 2010; 16(1):251-280.
• 43. Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 2006; 6:135-145.
• 44. Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane, Cancer Lett 2008; 269:291-304.
• 45. Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005; 280:19911-19924.
• 46. Xiao D, Powolny AA, Antosiewicz J, Hahm ER, Bommareddy A, Zeng Y, Desai DS, Amin S, Herman-Antosiewicz A, Singh SV. Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species. Pharm Res 2009; 26:1729-1738.
• 47. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L, Baskaran R. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 2004; 279:25813-25822.
• 48. James D, Devaraj S, Bellur P, Lakkanna S, Vicini J, Boddupalli S. Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli. Nutr Rev 2012; 70(11):654-665
• 49. Baux A, Hebeisen T, Pellet D. Effects of minimal temperatures on low-linolenic rapeseed oil fatty-acid composition. European Journal of Agronomy. 2008; 29:102-107.
• 50. Rudzińska M, Muśnicki Cz, Wąsowicz E. Phytosterols and their oxidized derivatives in seeds of winter oilseed rape. Oilseed Crops 2003; 24:51-66.
• 51. Gromadzka J, Wardencki W. Trends in Edible Vegetable Oils Analysis. Part A. Determination of different components of edible oils – a review. Pol J Food Nutr Sci 2011; 61(1):33-43.
• 52. PDR [Physicians Desk Reference] for Herbal Medicines, 4th Edition, 2007:615-616.
• 53. El-Beltagi H, Mohamed AA. Variations in fatty acid composition, glucosinolate profile and some phytochemical contents in selected oil seed rape (Brassica napus L.) cultivars. Grasas Y Aceites 2010; 61(2):143-150.
• 54. Pei D, Liu JX, Di DL. Cerebroside and ceramide from the pollen of Brassica napus L. Fitoterapia 2010; 81(7):838-43.
• 55. Zhu F, Zhao WC, Zhao XE, Suo YR, Liu SJ, You JM. Determination of long chain fatty acids in bryophyte plants extracts HPLC with fluorescent detection and identification with MS. J Chormatogr B 2007; 848:283-291.
• 56. Yang X, Guo D, Zhang J, Wu M. Characterization and antitumor activity of pollen polysaccharide. Int Immunopharmacol. 2007;7(4):427-34.
• 57. Chester C, Golebiowski T, Leong AS. The role of tocopherols in canola seed. In:12th Australian Research Assembly on Brassicas; 2001 ARAB; Australia 2001:200-202.
• 58. Malíková J, Swaczynová J, Z. Kolár Z, Strnad M. Anticancer and antiproliferative activity of natural brassinosteroids. Phytochemistry 2008; 69:418-426.
• 59. Clouse SD. Brassinosteroid signaling: novel downstream components emerge. Curr Biol 2002; 12:485-487.
• 60. Kripach VA, Zhabinski V, de Groot AE. A new class of plant hormones. Academic Press, San Diego 1999:456.
• 61. Chen YZ. Nutrition and antitumor. In: Berkey GE (ed.). Cancer: how to prevent it and how to help your doctor fight it. Science Press, Beijing 1985:50-52.
• 62. Nagai T, Inoue R, Inoue H, Suzuki N. Scavenging capacities of pollen extracts from cistus ladaniferus on autoxidation, superoxide radicals, hydroxyl radicals and DPPH radicals. NutrRes 2002; 22:519-526.
• 63. Heggen E, Granlund L, Pedersen JL, Holme I, Ceglarek U, Thiery J, Kirkhus B, Tonstad S. Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations. Nutr Metab Cardiovasc Dis 2010; 20(4):258-265.
• 64. Steigerová J, Oklešťková J, Levková M, Rárová L, Kolář Z, Strnad M. Brassinosteroids cause cell cycle arrest and apoptosis of human breast cancer cells. Chem Biol Interact 2010; 188(3):487-96.
• 65. Wu YD, Lou YJ. A steroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells. Phytother Res 2007; 21(11):1087-91.
• 66. Ursin VM. Modification of plants for human health: development of functional land-bases omega – 3 fatty acids. J Nutr 2003; 133:4271-4274.
• 67. Akinsete JA, Ion G, Witteand TR, Hardman WE. Consumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis 2012; 33:140-148.
• 68. Pasko PI, Bukowska-Strakova K, Gdula-Argasińska J, Tyszka-Czochara M. Rutabaga (Brassica napus L. var. napobrassica) seeds, roots, and sprouts: a novel kind of food with antioxidant properties and proapoptotic potential in Hep G2 hepatoma cell line. J Med Food 2013; 16(8):749-759.
• 69. Takahashi SI, Takeshita K, Seeni A, Sugiura S, Tang M, Sato SY, Kuriyama H, Nakadate M, Abe K, Maeno Y, Nagao M, Shirai T. Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspose signaling. Prostate 2009; 69(6):644-651.
• 70. Campbell SEI, Musich PR, Whaley SG, Stimmel JB, Leesnitzer LM, Dessus-Babus S, Duffourc M, Stone W, Newman RA, Yang P, Krishnan K. Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells. Nutr Cancer 2009; 61(5):649-662.
• 71. Campbell SEI, Rudder B, Phillips RB, Whaley SG, Stimmel JB, Leesnitzer LM, Lightner J, Dessus-Babus S, Duffourc M, Stone WL, Menter DG, Newman RA, Yang P, Aggarwal BB, Krishnan K. γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer. Free Radic Biol Med 2011; 50(10):1344-1354.

Identyfikatory

DOI

10.2478/hepo-2014-0018